About Renuka Iyer
Positions
Roswell Park Comprehensive Cancer Center
- Professor of Oncology
- Co-Director, Liver and Pancreas Tumor Center
- Section Chief for Gastrointestinal Oncology
Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo
- Professor of Medicine
Background
Education and Training:
- 1998 - MD - Grant Medical College, University of Mumbai, Maharashtra, India
Residency:
- 1998-2001 - Resident - Internal Medicine, Lincoln Medical and Mental Health Center and Cornell University School of Medicine, Bronx, NY
- 1997-1998 - Postdoctoral Associate- Fox Chase Cancer Center, Philadelphia, PA
Fellowship:
- 2001-2004 - Medical Oncology, Roswell Park Cancer Institute, Buffalo, NY
Board Certification:
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Professional Memberships:
- Cholangiocarcinoma Foundation
- Cholangiocarcinoma Foundation - Medical Advisory Board
- Cholangiocarcinoma Foundation - Nursing Advisory Board
- NANETs
- NANETs - Regional Conference Committee Chair
- Hepatobiliary Cancer Panel, National Comprehensive Cancer Network
- American Association for Cancer Research
- Carcinoid.org NET Physician/Expert
- American Association for the Study of Liver Diseases
- American College of Gastroenterology
- American College of Surgeons Oncology Group
- American Society of Clinical Oncology
Honors & Awards:
- June 2018 - Best Teacher Award, Awarded by Roswell Park Comprehensive Cancer Center Medical Oncology Fellows
- June 2008 - Best Teacher Award, Awarded by Roswell Park Comprehensive Cancer Center Medical Oncology Fellows
- January 2008 - American Cancer Society Scholar Award
- November 2007 - EORTC-NCI-ASCO Molecular Markers Development Workshop, Brussels, Belgium
- April 2003 - Thomas Frawley Resident Research Fellowship award, by State University of New York at Buffalo
- July 2002 - ASCO-AACR Methods in Clinical Cancer Research Workshop, Vail, CO
- October 1997 - Junior Investigator Award by the Executive Committee of the Tenth International Conference on Chemical Modifiers in Cancer Treatment
